Citicoline Injection 250mg/ml, 500mg/ml Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250mg/ml, 500mg/ml
Reference Brands: Somazina (EU), Cebrum (LATAM)
Category: Antipsychotropic Drugs
Citicoline is used in the treatment of stroke, head injury, Alzheimer's disease and dementia in Parkinson's disease. Citicoline is a nerve protecting medicine. It works on the brain by nourishing the nerve cells, protects them from damage and improves their survival.
Product Description:
Citicoline, the generic name for cytidine-5′-diphosphocholine (CDP-choline), is a naturally occurring compound and a key precursor of phospholipid phosphatidylcholine, an essential component of neuronal cell membranes. After oral or injectable administration, citicoline is rapidly metabolized into cytidine and choline, which cross the blood-brain barrier and are used by brain cells to resynthesize CDP-choline. This process supports membrane repair, neurotransmitter synthesis—particularly acetylcholine—and overall neuronal function.
Preclinical studies have demonstrated citicoline’s neuroprotective effects in models of brain ischemia and trauma, suggesting its potential to reduce neuronal damage and support recovery. While large clinical trials in acute conditions such as ischemic stroke and traumatic brain injury have not consistently shown significant benefits, citicoline appears to be useful in slowly progressive neurodegenerative conditions, including mild vascular cognitive impairment and glaucoma.
The exact mechanisms of citicoline’s pharmacological activity remain under investigation. Emerging evidence suggests that, despite rapid metabolism, the intact molecule or intermediate hydrolysis products like cytidine monophosphate and phosphocholine may have pharmacological activity, contributing to neuroprotection and cognitive support. Overall, citicoline serves as a valuable agent in supporting brain health, promoting neuronal repair, and aiding cognitive function in specific neurological conditions.
Citicoline Injection — third party manufacturing & bulk supply
Citicoline Injection 250mg/ml, 500mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Citicoline Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Citicoline Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Citicoline Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Citicoline Injection is used to support brain health, particularly in acute neurological conditions. It is commonly prescribed for patients recovering from stroke, traumatic brain injury, or other cerebrovascular disorders. The injection helps improve cognitive function, enhances memory, supports neuronal repair, and aids recovery from brain injuries by promoting the synthesis of essential phospholipids in nerve cell membranes.
Citicoline Injection contains Citicoline (cytidine 5’-diphosphocholine or CDP-choline) as the active ingredient. It supplies choline and cytidine, which are essential for the synthesis of phosphatidylcholine, a critical component of neuronal membranes, and supports acetylcholine production for improved neurotransmission. The injection also contains stabilizers and excipients suitable for parenteral administration.
Common trade names include Somazina Injection, Ceraxon Injection, Cognizin IV, Neurocoline Injection, and Citicoline‑IV.
Citicoline Injection is manufactured by several pharmaceutical companies including Sun Pharma, Cadila Pharmaceuticals, Mylan, Intas Pharmaceuticals, and Kyowa Hakko, depending on the brand and region.
The generic name is Citicoline (CDP-choline) Injection.
Brand names include Somazina Injection, Ceraxon Injection, Cognizin IV, Neurocoline Injection, and Citicoline‑IV.
It is primarily manufactured in India, Japan, and Europe, and distributed globally for both hospital and clinical use in acute neurological conditions.
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View DetailsPhenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers